COMMUNIQUÉ DE PRESSE
News
-
-
-
COMMUNIQUÉ DE PRESSE
Route1 Announces Non-Brokered Private Placement for Gross Proceeds of Approximately C$500,000
Route1 Inc. announces non-brokered private placement of units at C$0.075 per Unit to fund development of AI Co-Pilot for optimizing parking operations. Offering expected to close in tranches starting November 19, 2025 -
COMMUNIQUÉ DE PRESSE
DBV Technologies participera à la 2e conférence annuelle Guggenheim Healthcare Innovation
DBV Technologies participera à la 2e conférence annuelle Guggenheim Healthcare Innovation avec Daniel Tassé, Directeur Général. Découvrez la webdiffusion en direct sur le patch VIASKIN® pour les allergies alimentaires -
-
-
-
COMMUNIQUÉ DE PRESSE
Zomedica Announces Third Quarter 2025 Financial Results: Revenue up 16% to $8.1 Million with 67% Gross Margins and $54 Million in Liquidity to Support Growth
Zomedica Corp. reports highest quarterly revenue ever and 19th consecutive year-over-year revenue growth, achieving $8.1M in sales. Record Diagnostics and Therapeutic Device segment performance drive success -
COMMUNIQUÉ DE PRESSE
In a landmark industry transaction, Evotec signs agreement with Sandoz, resulting in payments potentially over US$ 650 m plus royalties
Evotec SE signs landmark agreement with Sandoz, leading to over US$650m in payments plus royalties. Deal includes acquisition of manufacturing site and technology license fees -
COMMUNIQUÉ DE PRESSE
Sandoz boosts in-house biosimilars capabilities by signing agreement to acquire Just-Evotec Biologics EU SAS in Toulouse
Sandoz strengthens biosimilars capabilities with acquisition of Just-Evotec Biologics EU SAS in Toulouse. Acquisition aims to capture projected biosimilar market opportunity. Transaction includes cash payment and technology license fees
